Covered recipient · General Payments record
ROBERT S GOLDEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,615.88
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $424.78 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $156.44 | 7 |
| PFIZER INC. | $72.77 | 3 |
| Merck Sharp & Dohme Corporation | $65.79 | 3 |
| ABBVIE INC. | $44.63 | 2 |
| Amgen Inc. | $43.67 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.25 | 1 |
| Lilly USA, LLC | $13.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.72 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103810652 | CMS |
| ABBVIE INC. | $21.91 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103810654 | CMS |
| Amgen Inc. | $21.78 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563970 | CMS |
| Amgen Inc. | $21.89 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563972 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.25 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118266825 | CMS |
| Lilly USA, LLC | $13.23 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135385385 | CMS |
| Merck Sharp & Dohme LLC | $21.53 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141954377 | CMS |
| Merck Sharp & Dohme LLC | $23.35 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141827144 | CMS |
| Merck Sharp & Dohme LLC | $20.91 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141571653 | CMS |
| Novo Nordisk Inc | $24.51 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097026348 | CMS |
| Novo Nordisk Inc | $24.70 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607407 | CMS |
| Novo Nordisk Inc | $16.11 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096731897 | CMS |
| Novo Nordisk Inc | $23.83 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096956739 | CMS |
| Novo Nordisk Inc | $21.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097448661 | CMS |
| Novo Nordisk Inc | $18.03 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097061977 | CMS |
| Novo Nordisk Inc | $27.93 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097009572 | CMS |
| PFIZER INC. | $26.06 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205600 | CMS |
| PFIZER INC. | $21.95 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131973205 | CMS |
| PFIZER INC. | $24.76 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205349 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.